Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell × merphos × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Burkitt Lymphoma 20 Leukemia, Myeloid, Acute 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myelomonocytic, Chronic 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hodgkin Disease 5 Congenital Abnormalities 5 Lymphoma, Large-Cell, Anaplastic 4 Leukemia, Myeloid, Accelerated Phase 4 Leukemia, Biphenotypic, Acute 4 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Hematologic Neoplasms 3 Chromosome 5q Deletion Syndrome 3 Breast Neoplasms 3 Blast Crisis 3 Anemia, Refractory, with Excess of Blasts 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Recurrence 2 Primary Myelofibrosis 2

Interventions

Cyclophosphamide 13 Etoposide 10 Prednisone 8 Doxorubicin 8 Whole-Body Irradiation 7 Vincristine 7 Rituximab 7 Peripheral Blood Stem Cell Transplantation 7 Melphalan 7 Brentuximab Vedotin 7 romidepsin 6 fludarabine phosphate 6 Mycophenolic Acid 6 fludarabine 5 Lenalidomide 5 Gemcitabine 5 Cytarabine 5 10-propargyl-10-deazaaminopterin 5 Tacrolimus 4 Granulocyte Colony-Stimulating Factor 4 Carmustine 4 Busulfan 4 Antilymphocyte Serum 4 pembrolizumab 3 etoposide phosphate 3 carmustine, poliferprosan 20 drug combination 3 Vorinostat 3 Sirolimus 3 Nivolumab 3 Filgrastim 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡